Health Catalyst, Inc Common Stock

Oct 22, 2026

Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026

Health Catalyst will announce its third quarter 2026 operating results on November 5, 2026, after market close. A conference call to discuss these results will take place at 5:00 pm ET on the same day. Participants can join via phone or through a live audio webcast.

Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Health Catalyst, Inc. announced the grant of 2,747,385 restricted stock units to Simeon Kohl as part of his inducement for joining as CEO. The RSUs will vest over time, contingent on his continued employment. This move is in accordance with Nasdaq Listing Rule 5635(c)(4), which allows inducement awards for new executives.

Sep 14, 2026

▼ -5.5%on this newsshared move

Health Catalyst Strengthens Its Board with the Appointment of Tami Reller

Health Catalyst has appointed Tami Reller to its board of directors, effective October 1, 2026. Reller, who has significant experience in healthcare and technology, will serve as audit chair and on the compensation committee. This appointment follows the recent naming of Simeon Kohl as CEO, as the company aims to enhance its growth strategy and leverage its AI-driven healthcare solutions.

Sep 8, 2026

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Health Catalyst has appointed Simeon Kohl as its new CEO and President, effective September 14, 2026. Kohl, who previously led Performant Healthcare, will succeed Ben Albert, who will transition to Chief Business Officer. This leadership change aims to enhance Health Catalyst's strategic focus on AI-driven healthcare solutions and operational performance, while Albert remains involved in advancing the company's priorities.

Aug 31, 2026

Health Catalyst to Participate in Upcoming Investor Conference

Health Catalyst, a healthcare intelligence company, announced its participation in the 2026 Wells Fargo Healthcare Conference. The event will take place in Boston on September 9 and 10, 2026. This engagement reflects the company's commitment to improving health systems through data-driven solutions and measurable outcomes.

Aug 6, 2026

Health Catalyst Reports Second Quarter 2026 Results

Health Catalyst reported strong financial results for Q2 2026, exceeding revenue expectations. The company successfully completed the divestiture of Vitalware and repaid its credit facility debt, enhancing its financial flexibility. Looking ahead, Health Catalyst anticipates total revenue of $246 million to $249 million for the full year 2026.

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst has successfully completed the sale of Vitalware to Med-Metrix, allowing the company to retire its credit facility debt. This strategic move enables Health Catalyst to concentrate on its core technology aimed at improving health system performance. The transaction, valued at $147 million, is expected to enhance the company's financial flexibility and support its investment in AI-driven healthcare intelligence products.

Jul 28, 2026

Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026

Health Catalyst, Inc. will announce its second quarter 2026 operating results on August 6, 2026, after market close. A conference call will follow at 5:00 pm ET to discuss the results. Participants can join via phone or through a live audio webcast. The company emphasizes its role in improving health systems through data-driven actions.

Jul 28, 2026

MidCap Advisors Advises Leading Midwest Psychiatric Care Provider in Its Acquisition by Health Catalyst Capital

MidCap Advisors has successfully advised a Midwest psychiatric care provider in its acquisition by Health Catalyst Capital. This partnership aims to expand the provider's reach and enhance care quality for elderly and disabled adults. The acquisition is expected to leverage HCC's healthcare network and operational expertise to foster growth.

Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation

Health Catalyst, Inc. has announced an agreement to divest its mid-revenue cycle unit, Vitalware, to Med-Metrix for $147 million in cash. This move aligns with Health Catalyst's strategy to concentrate on its core technology and AI investments aimed at enhancing health systems' performance. The proceeds from the sale will be utilized to pay off existing debts, which is expected to improve the company's financial standing. The transaction is anticipated to finalize in 2026, pending certain regulatory approval conditions.

May 11, 2026

▼ -9.2%on this news· ran to -23% by day 3

Health Catalyst Reports First Quarter 2026 Results

Health Catalyst, Inc. reported its financial results for Q1 2026, showing a revenue decline of 11% compared to the previous year. Despite this dip, the company announced that revenue and adjusted EBITDA exceeded expectations, reflecting efforts in its strategic reset. The net loss has significantly increased, which the company attributed to several uncontrollable factors. Looking ahead, Health Catalyst provided revenue guidance for Q2 2026 and the full year, signaling cautious optimism amid financial challenges.

May 1, 2026

▲ +16%on this news

Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

Health Catalyst, Inc. will announce its first quarter 2026 operating results on May 11, 2026, after market close. The company will also host a conference call at 5:00 pm ET to review these results. Participants can access the call via phone or a live audio webcast, with a replay available for 90 days.

Apr 30, 2026

Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors Nelson Joins as the Company Builds the Leadership Infrastructure for Its Next Phase

Health Catalyst announced the appointment of Steve Nelson, current President of Aetna, to its Board of Directors, effective May 1, 2026. This appointment follows recent leadership changes, including the naming of Ben Albert as CEO. Nelson brings significant experience from various leadership roles in healthcare, which Health Catalyst views as essential for executing their strategy aimed at improving health system performance. Nelson expressed his enthusiasm for joining the company during a pivotal time in the healthcare landscape.

Health Catalyst Reports Fourth Quarter and Year End 2025 Results

Health Catalyst reported strong financial results for Q4 and the full year of 2025, with total revenue of $311.1 million and an Adjusted EBITDA of $41.4 million. CEO Ben Albert highlighted both opportunities and areas for improvement as the company focuses on long-term success. However, the company is not providing guidance for 2026 due to an ongoing internal strategic review.

Mar 2, 2026

Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026

Health Catalyst, Inc. will announce its fourth quarter and year-end 2025 operating results on March 12, 2026. Following the announcement, the company will host a conference call at 5:00 pm ET to discuss the results. Participants can access the call via phone or a live audio webcast, with a replay available afterward.

Feb 18, 2026

Health Catalyst Appoints Ben Albert as Chief Executive Officer Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in Healthcare

Health Catalyst has appointed Ben Albert as the new Chief Executive Officer, effective February 12, 2026. Albert, who previously served as the President and COO, aims to enhance operational efficiency and clinical quality while improving consumer experience. The board of directors will also be reduced to five members, including Albert, following the departure of several directors. This leadership shift is part of Health Catalyst's strategy to align resources with high-return priorities and support improved financial performance.

Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors

Health Catalyst, Inc. has appointed Matt Arens, CEO and Founder of First Light Asset Management, to its board of directors, effective immediately. First Light is the largest shareholder of Health Catalyst, owning over 13 million shares. Arens brings nearly 30 years of investment experience, particularly in healthcare, and has a strong track record in capital markets. His appointment is expected to provide valuable insights for the company as it pursues growth and shareholder value. In related news, Matthew Kolb will not seek re-election to the board at the 2026 annual meeting.

Nov 10, 2025

Health Catalyst Reports Third Quarter 2025 Results

Health Catalyst reported its financial results for the third quarter of 2025, highlighting a total revenue of $76.3 million and an Adjusted EBITDA of $12 million. Both measures surpassed the company’s guidance for the quarter. However, the company also reported a net loss of $22.2 million, which represents a significant increase from the prior year. Despite the losses, Health Catalyst remains optimistic about its full-year projections for 2025.

Sep 10, 2025